Real Life Study of Lenvatinib Therapy for Hepatocellular Carcinoma: RELEVANT Study

Conclusions: Our study confirms in a large and global population of patients with advanced HCC, not candidates for locoregional treatment the OS reported in the registration study and a high response rate with lenvatinib.
Source: Liver Cancer - Category: Cancer & Oncology Source Type: research